Cowen analyst Yaron Werber initiates coverage on Roivant Sciences (NASDAQ: ROIV) with an Outperform rating.The analyst commented, "Roivant aims to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE